- decreased circulating HDL cholesterol level / IMPC
- decreased circulating calcium level / IMPC
- decreased hematocrit / IMPC
- increased monocyte cell number / IMPC
- abnormal head morphology / IMPC
- abnormal forelimb morphology / IMPC
- abnormal hindlimb morphology / IMPC
- enlarged spleen / IMPC
- tremors / IMPC
- abnormal locomotor behavior / IMPC
- decreased locomotor activity / IMPC
- abnormal gait / IMPC
- decreased exploration in new environment / IMPC
- abnormal startle reflex / IMPC
- decreased startle reflex / IMPC
- increased mean corpuscular volume / IMPC
- decreased circulating triglyceride level / IMPC
- increased heart weight / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- increased spleen weight / IMPC
- decreased circulating cholesterol level / IMPC
- narrow eye opening / IMPC
- decreased heart rate / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating glucose level / IMPC
- increased mean corpuscular hemoglobin / IMPC
- decreased circulating total protein level / IMPC
- increased circulating potassium level / IMPC
- increased circulating iron level / IMPC
- decreased prepulse inhibition / IMPC
- impaired cued conditioning behavior / IMPC
- prolonged RR interval / IMPC
- abnormal freezing behavior / IMPC
- increased freezing behavior / IMPC
C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H
| Status | Only small colony available |
| EMMA ID | EM:16891 |
| Citation information | RRID:IMSR_EM:16891 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H |
| Alternative name | HEPD0507_5_A09 |
| Strain type | Targeted Mutant Strains |
| Allele/Transgene symbol | Ctsatm2b(EUCOMM)Hmgu |
| Gene/Transgene symbol | Ctsa |
| Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
| Provider | Mary Lyon Centre at MRC Harwell |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | This mouse line originates from EUCOMM ES clone HEPD0507_5_A09. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele. Click here for more information on EUCOMM final vectors. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Galactosialidosis / Orphanet_351
- Cathepsin A-related arteriopathy-strokes-leukoencephalopathy / Orphanet_575553
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating glucose level / IMPC
- increased freezing behavior / IMPC
- decreased circulating calcium level / IMPC
- abnormal gait / IMPC
- decreased circulating triglyceride level / IMPC
- abnormal head morphology / IMPC
- impaired cued conditioning behavior / IMPC
- abnormal locomotor behavior / IMPC
- decreased locomotor activity / IMPC
- narrow eye opening / IMPC
- increased circulating iron level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal startle reflex / IMPC
- increased spleen weight / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased prepulse inhibition / IMPC
- decreased hemoglobin content / IMPC
- increased mean corpuscular hemoglobin / IMPC
- increased monocyte cell number / IMPC
- increased mean corpuscular volume / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- thrombocytopenia / IMPC
- tremors / IMPC
- decreased erythrocyte cell number / IMPC
- decreased exploration in new environment / IMPC
- increased circulating potassium level / IMPC
- decreased circulating total protein level / IMPC
- abnormal freezing behavior / IMPC
- prolonged RR interval / IMPC
- enlarged spleen / IMPC
- decreased hematocrit / IMPC
- decreased heart rate / IMPC
- increased circulating bilirubin level / IMPC
- abnormal forelimb morphology / IMPC
- decreased startle reflex / IMPC
- decreased circulating serum albumin level / IMPC
- abnormal hindlimb morphology / IMPC
- increased heart weight / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
